Main content

Freshfields advises Charterhouse Capital Partners and its portfolio company, SERB Specialty Pharmaceuticals, on SERB’s acquisition of BTG Specialty Pharmaceuticals

Freshfields advised Charterhouse Capital Partners LLP and its portfolio companies, Stark International Lux S.à r.l and SERB SAS (together, SERB), on SERB’s pending acquisition of the BTG Specialty Pharmaceuticals business from Boston Scientific Corporation, for a cash purchase price of $800 million. The transaction is expected to close in the first half of 2021, subject to customary regulatory approvals and other customary closing conditions.
 
The deal was financed by ICG Alternative Investment Limited, who provided 800m€ equivalent Unitranche financing, and with new equity provided by Partners Group, Merieux Equity Partners and existing shareholders.
 
SERB owns a diversified portfolio of prescription medicines focused on rare and life-threatening diseases. The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.
 
The Freshfields corporate team is being led by partners Yann Gozal in Paris and Paul Humphreys in New York, with assistance from corporate associates Stephen Wilkinson, Simon Dievart, Kamile Bougdira, Brianna Cummings and Anthony Paladino. Finance advice is being provided by partners Aled Batey, Stéphanie Corbière and Kyle Lakin, counsel Gabriel Glover-Bondeau, senior associate Richard Daniels, associates Sonam Cheema and Samvel Der Arsenian and trainee Tiffany Hui. CFIUS advice is being provided by partner Aimen Mir and special counsel Christine Laciak. Antitrust advice is being provided by partner Mary Lehner, counsel Aude Guyon, senior associate Ilana Kattan and associate Maud Chanover. Anti-bribery and corruption advice is being provided by counsel Stephanie Brown Cripps and associate Weronika Bukowski. English corporate law advice is being provided by partner Charles Hayes, associates Hugh Laundry and George Clarke and trainee Olivia Retter. Intellectual property and carve-out advice is being provided by principal associate Philipp Dohnke and associates Aljosh Barath and Maximilian Zellerhoff.  
 
ENDS

About Freshfields Bruckhaus Deringer


Freshfields Bruckhaus Deringer is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.

This material is for general information only and is not intended to provide legal advice. Prior results do not guarantee a similar outcome.

The Freshfields team was led by: